Mukhtarova, Liliya A.,
Fedorova, Yulia Yu.,
Karunas, Aleksandra S.,
Prokofyeva, Darya S.,
Nurgalieva, Alfia Kh.,
Khusnutdinova, Elza K.,
Zagidullin, Shamil Z. (2023) , we
assessed predictors of the
risks of exacerbation and death in BA and built multivariate models
Valeeva, E.T.,
Galimova, R.R.,
Distanova, A.A.,
Suleymanova, I.F.,
Suleymanova, I.F.,
Boyarinova, N.B.,
Salavatova, L.Kh.,
Isaeva, S.M. (2023) records got longer, and were more frequently exacerbated with acute cardiovascular conditions. We
assessedXu, Dongxiao,
Guo, Jiaojiao,
Zheng, Bingjie,
Wu, Qiaowei,
Gareev, Ilgiz,
Beylerli, Ozal,
Beilerli, Aferin,
Shi, Huaizhang (2023) , and there is no consensus on the
risk factors associated with it. Aim: The aim of this study was to determine the
riskKazantseva, Anastasiya,
Davydova, Yuliya,
Enikeeva, Renata,
Mustafin, Rustam,
Malykh, Sergey,
Lobaskova, Marina,
Kanapin, Alexander,
Prokopenko, Inga,
Khusnutdinova, Elza (2023) assessment of individuals with elevated
risk for developing depression in a non-clinical group is of high
Shnayder, N.A.,
Grechkina, V.V.,
Khasanova, A.K.,
Bochanova, E.N.,
Dontceva, E.A.,
Petrova, M.M.,
Asadullin, A.R.,
Shipulin, G.A.,
Altynbekov, K.S.,
Al-Zamil, M.,
Nasyrova, R.F. (2023) approach to
assessing the cumulative
risk of developing VPA-induced adverse reactions is presented and ways